Futures dipped in Tokyo and rose in Hong Kong and Australia Asian stocks looked set for a mixed start to trading after a U.S.
rally faltered on a report a leading experimental coronavirus drug performed poorly in a test. Oil climbed back above $16 a barrel.
Futures dipped in Tokyo and rose in Hong Kong and Australia. S&P 500 contracts edged lower after the gauge erased a 1.6% gain in Thursday’s session to end little changed.
Gilead Sciences Inc.’s antiviral drug remdesivir flopped in its first randomized clinical trial, the Financial Times reported, citing draft documents published accidentally by the World Health Organization.